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Edited by Gianni CesareniAbstract Male germ cells speciﬁcally express paralogues of
components of the general transcription apparatus including
ALF a paralogue of TFIIAa/b. We show that endogenous
ALF is proteolytically cleaved to give a- and b-subunits and
we map the proteolytic cleavage site by mass spectrometry.
Immunoprecipitations show that ALFa- and b-subunits form a
series of homologous and heterologous complexes with somatic
TFIIA which is coexpressed in male germ cells. In addition, we
show that ALF is coexpressed in late pachytene spermatocytes
and in haploid round spermatids with transcription factor
TRF2, and that these proteins form stable complexes in testis ex-
tracts. Our observations highlight how cleavage of ALF and
coexpression with TFIIA and TRF2 increases the combinatorial
possibilities for gene regulation at diﬀerent developmental stages
of spermatogenesis.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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spectrometry1. Introduction
Transcription of eukaryotic genes requires RNA polymerase
(pol)II and a group of general transcription factors (GTFs)
(TFIIA, -B,-D, -E, -F, and -H), which contribute to the forma-
tion of the preinitiation complex (PIC) at the core promoter
[1,2]. The correct assembly of the PIC is a critical step in the
initiation of transcription of class II genes.
The basal transcription factor TFIIA interacts with the
TATA binding protein (TBP) and stabilises its binding to the
TATA element [3–5]. TFIIA can also stimulate transcription
by competing for binding to TBP with transcriptional repres-
sors such as NC2 [6–9].*Corresponding author. Fax: +33 3 88 65 32 01.
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doi:10.1016/j.febslet.2005.04.083TFIIA consists of large (e.g., yeast TOA1, Drosophila
TFIIA-L, human TFIIAa/b) and small (e.g., yeast TOA2, Dro-
sophila TFIIA-S, human TFIIAc) subunits [7,8,10–12]. The N-
terminal and the C-terminal domains of the large subunit are
highly conserved and structured and interact with the c-sub-
unit to form a two-domain, boot shaped structure [13,14]. A
non-conserved spacer of variable size separates the structured
domains, which is largely unstructured. In higher eukaryotes,
the large subunit is post-translationally cleaved in the linker re-
gion generating two separate subunits (a and b) each contain-
ing one of the structured domains. The a- and b-subunits
associate with distinct domains of the c-subunit to form a tri-
meric complex that binds to TBP.
TFIIAa/b and c are ubiquitously expressed in somatic tis-
sues and are upregulated in male germ cells [15,16]. How-
ever in addition to the TFIIA subunits, male germ cells
also express a paralogue of TFIIAa/b designated TFIIA-like
factor (ALF, see [17]) or TFIIAs [18]. The ALF mRNA
ﬁrst appears in mouse testis at postnatal day 14 and is pres-
ent in pachytene spermatocytes and haploid spermatids [15],
however the expression proﬁle and localisation of the corre-
sponding protein is not known. ALF has a similar domain
organisation to TFIIAa/b where the non-conserved linker
region is approximately 100 residues longer in ALF. None-
theless, full length recombinant ALF has in vitro biochem-
ical properties very similar to those of TFIIAa/b. ALF can
form a complex with recombinant TFIIAc that can stabilise
the binding of TBP to DNA and restore transcriptional
activity to TFIIA-depleted HeLa cell nuclear extracts
[18,19].
In this study, we show that endogenous mouse ALF is
cleaved into a- and b-subunits in testis and we identify the
cleavage site by MALDI-TOF analysis. Immunoprecipitation
of testis extracts reveals the existence of a combinatorial pop-
ulation of homologous and heterologous complexes generated
by intermixing of the somatic TFIIA and germ cell speciﬁc
ALFa- and b-subunits. We further demonstrate that the
ALF/TFIIA factors form stable complexes with TBP-related
factor 2 (TRF2) in testis extracts and that they are coexpresed
at speciﬁc stages of germ cell diﬀerentiation. Our results there-
fore highlight the combinatorial possibilities provided by the
co-expression of the ALF and TFIIA subunits in male germ
cells to form heterologous complexes and to interact with the
testis-speciﬁc TRF2.blished by Elsevier B.V. All rights reserved.
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2.1. Immunoblots and immunohistochemistry
Mouse seminiferous tubule segments at deﬁned stages were isolated
using the transillumination-assisted microdissection method [20].
Immunohistochemistry was performed on staged squash preparations
of microdissected tubules from wild-type C57 BL/6 mice as previously
described [21]. Antibodies against TBP, TRF2, CREB, TAF7L are as
previously described [22–24]. The antibody against TFIIAa and
TFIIAb are a kind gift from H.G. Stunnenberg. Monoclonal antibody
(2B11) was generated against ALF peptide A, aa 286-
QLQSLKDSIYGCDSTKQLRK-305 coupled ovalbumin as previ-
ously described [25]. A second rabbit polyclonal anti-ALF antibody
was raised against peptide B aa 379-DSVSNEDSTANSSDNEDH-
QI-398. The rabbit serum was puriﬁed by chromatography against
the immobilised peptide. The relative locations of peptides A and B
are indicated in Fig. 3.
2.2. Extract preparation and immunoprecipitation
Cytoplasmic and nuclear mouse testis extracts were prepared as pre-
viously described [23]. The cytoplasmic extract from 20 mouse testes
was then loaded on a DEAE column in 400 mM KCl. The ﬂow
through fraction contained all the ALF and was used to perform the
IPs in 200 mMKCl. A control immunoprecipitation with the anti-Flag
antibody was ﬁrst performed, and the supernatant from this IP was
then subjected to two successive IPs with the anti-ALF monoclonal
antibody. The IPs were washed three times for 10 min with 500 mM
KCl and then once for 5 min with 100 mM KCl. The immunoprecipi-
tated proteins were eluted with Laemli buﬀer, separated by 10%
SDS–PAGE and detected by silver nitrate staining [26]. Slices from
silver nitrate stained gel were excised and subjected to MALDI TOF
spectrometry analysis.
2.3. In gel digestion
Digestion of excised bands was performed as previously described
[27]. According to the gel band volume, 5–10 ll of 10 ng/ll Trypsin
(Promega) or 10 ng/ll Lys-C (Roche) were added. Both enzymes were
freshly diluted in 25 mM NH4HCO3. The digestion was performed
overnight at 30 C. 5 ll of 40% H2O/60% acetonitrile/0.1% TFA were
added and samples were left for 4 h at room temperature. Then the
mixtures were sonicated for 2 min and centrifuged. 0.5 ll of superna-
tant was used for MALDI analysis.
2.4. MALDI MS
Peptide extracts (0.5 ll) weremixedwith an equal volume of saturated
DHB (Sigma) dissolved in 20% acetonitrile and applied to the target.
MALDI mass measurements were carried out on a Bruker Reﬂex IV
MALDI-TOF spectrometer. This instrument was used at a maximum
accelerating potential of20 kV (in positivemode) or 20 kV (in negative
mode) and was operated in reﬂector mode. The acquisition mass range
was 800–3000 Da with low mass gate set at 700 Da. For positive mode
measurements after trypsin digestion, internal calibration was per-
formed using autolytic trypsin peptides (MH+: m/z = 842.51 and m/
z = 2211.11). For negative mode measurements and after Lys-C diges-
tion, calibration was performed using ALF-speciﬁc peptides (MH: m/
z = 802.45 and m/z = 1617.81. MH+: m/z = 943.56 and m/z = 1857.02).
Monoisotopic peptidemasses were assigned using the Bruker FlexAnal-
ysis software. FindMod and FindPep tools (http://www.expasy.org/
tools/) were used to analyse the ALF spectra. The Profound program
was used for database searching (http://prowl.rockefeller.edu/) with
the following parameters: database NCBI, taxonomy mammalia, pro-
tein mass range 0–100 kDa, trypsin digestion with one missed cleavage
allowed, cysteines modiﬁed by carbamidomethylation, methionine oxi-
dation and mass tolerance of 75 ppm.3. Results
3.1. Characterisation of endogenous ALF in mouse testis
extracts
ALF and TFIIA share extensive similarity in their N-terminal
and C-terminal regions, while the intervening sequence is lessconserved [17]. In order to study the role of ALF during mouse
spermatogenesis, we generated amonoclonal antibody against a
synthetic peptide located in a region that is not conserved be-
tween TFIIAa/b and ALF to avoid any cross reactivity (mALF:
aa 286–305, see Section 2). This antibody recognises recombi-
nant ALF expressed in transfected Cos 1 cells (data not shown).
The antibody was then used to detect endogenous ALF by
immunoblot analysis of cytoplasmic and nuclear extracts pre-
pared from whole adult mouse testis. The ALF antibody
recognised two proteins of 70 and 40 kDa (Fig. 1A). Surpris-
ingly, both of these proteins were almost exclusively present
in the cytoplasmic fraction. In contrast, but as expected, nuclear
proteins such as TBP and CREB were mainly present in the
nuclear extracts (Fig. 1A, lane 2), while TAF7L, whose expres-
sion we had previously shown to be cytoplasmic and nuclear
[23], was detected in both fractions (Fig. 1A).
Although the 70 kDa protein corresponds to the migration
of the full length recombinant protein, the faster migrating
species could correspond to a proteolytically cleaved form of
ALF. To test this possibility we performed an immunoprecip-
itation (IP) from cytoplasmic testis extract with the ALF anti-
body. A control immunoprecipitation with the anti-Flag
antibody precipitated neither the 70 kDa nor the 40 kDa spe-
cies (lane 2, Fig. 1B). In contrast, both species were speciﬁcally
immunoprecipitated with the anti-ALF antibody (lane 3).
ALF may therefore be cleaved in mouse testis into a- and b-
subunits analogous to what has been described for TFIIA a/b.3.2. Identiﬁcation of the ALFa C-terminus
To characterise the 40 kDa subunit, we made a large scale
immunoprecipitation from a cytoplasmic testis extract (see
Section 2). A control immunoprecipitation with anti-Flag anti-
body was ﬁrst made before precipitation with the anti-ALF
monoclonal antibody. Analysis of the immunoprecipitates by
SDS–PAGE and silver nitrate staining (Fig. 2A) showed a
prominent 40 kDa species speciﬁcally present in the anti-
ALF IP (Fig. 2A, lane 1). This protein and gel slices from
the region corresponding to the mass of full length ALF were
excised, digested with trypsin in gel, and subjected to MALDI
mass spectrometry analysis in the classical positive mode.
Although no prominent silver-stained band corresponding
to the full length ALF protein was clearly observed, MALDI
peptide mass ﬁnger-printing (PMF) of one of the gel slices
from this 70 kDa region reveals the presence of 11 ALF tryptic
peptides homogenously distributed along the ALF protein se-
quence (Fig. 2B). MALDI PMF of the 40 kDa species shows
several speciﬁc peaks (data not shown) corresponding to 13
ALF tryptic peptides spanning the N-terminal two thirds of
the protein (Fig. 2B). These results indicate that the 40 kDa
species is indeed the ALFa-subunit.
To identify the C-terminus of the ALFa-subunit, we com-
pared the MALDI PMF spectra of the 70 and 40 kDa ALF
species. Three peaks (data not shown) corresponding to 2 C-
terminal ALF peptides (329–356 and 446–454) were absent
from the 40 kDa spectrum (Fig. 2B) suggesting that the C-ter-
minus of ALFa is before amino acid 356. To precisely map the
C-terminus, the MALDI PMF spectrum in positive mode was
carefully analysed, but did not show any speciﬁc peak, which
could correspond to the ALFa C-terminal peptide (data not
shown). However, as the ALF sequence between amino acids
329 and 356 is highly acidic, thereby decreasing dramatically
Fig. 1. Immunoprecipitation of ALF from testis extracts. (A) Cytoplasmic (Cy) or nuclear (Nu) extracts from mouse testis were probed with the
antibodies for the proteins indicated to the left of each sub-panel. In this panel the IgG(H) indicates small amounts of endogenous immunoglobulins
in the extract that originate from lymphocytes present in blood vessels in the testis. (B)–(E) In each panel the antibodies used to make the
immunoprecipitation are shown above each lane. Lane 1 is the cytoplasmic extract and lane 2 the control IP using the anti-FLAG antibody. The
antibodies used to probe the IPs are indicated to the left of each sub-panel.
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spectrum was recorded in the negative mode. ALF tryptic pep-
tides previously observed in positive mode were also detected
in negative mode, but importantly, a new m/z 1500.68 peak
was observed (Fig. 2C) corresponding to the strongly acidic
ALF peptide 329–341. To conﬁrm this, the 40 kDa species
was digested with the Lys-C protease. In the positive mode,
the m/z 2861.28 peak, corresponding to the Lys-C ALF peptide
318-341 (expected mass: 2861.36 Da), was observed (Fig. 2D).
These results unambiguously show that D341 is the C-termi-
nus of ALFa.
The MALDI TOF analysis described above revealed that
mALF is cleaved between D341 and G342. The D341 and
G342 residues are highly conserved in human and Xenopus
ALF and with TFIIAa/b of diﬀerent organisms except in Sac-
charomyces cerevisiae TOA1, which is not cleaved (Fig. 3).3.3. A combinatorial series of complexes between the ALF and
TFIIA subunits is present in testis extracts
While ALF expression is speciﬁc to germ cells, TFIIA has
also been shown to be strongly expressed in pre- and post-
meiotic cells [15,16]. In addition, our results show that ALF
is cleaved in testis to generate a- and b-subunits. The coexpres-sion of TFIIA and ALF, their cleavage, and their shared abil-
ity to interact with the TFIIA c-subunit, suggested the
possibility that there may be intermixing between the somatic
and the testis-speciﬁc subunits. To test this possibility, we
probed the testis extract using antibodies to the TFIIAa- and
b-subunits. Like ALF, TFIIAa and TFIIAb were predomi-
nantly detected in the cytoplasmic extract (Fig. 1A, lane 1).
These antibodies did not reveal detectable amounts of unc-
leaved TFIIA and did not cross react with the ALF subunits
(data not shown).
Immunoprecipitation of the cytoplasmic fraction with the
anti-ALF antibody not only precipitated full length ALF
and ALFa, it clearly and speciﬁcally coprecipitated TFIIAb
(Fig. 1B). Moreover, the ALFa antibody also precipitates
trace amounts of TFIIAa suggesting that a small amount of
TFIIAa can associate with the b-domain in full length ALF
(Fig. 1B, lane 3). In the reciprocal experiment, immunoprecip-
itation of TFIIAb brought down both TFIIAa and ALFa, but
little or no full length ALF (Fig. 1E). These results demon-
strate the existence of complexes with ALFa- and TFIIAb-
subunits.
We also generated a polyclonal antibody speciﬁc for the
ALFb-subunit (see Section 2 and peptide B in Fig. 3). This
antibody recognises ALF in transfected Cos cells, but does
Fig. 2. Proteolytic cleavage of ALF. (A) The proteins immunoprecipitated by the anti-FLAG and and anti-ALF antibodies are shown after SDS–
PAGE and staining with silver nitrate. The locations of full length ALF, ALFa, and TRF2 are indicated to the left. (B) Schematic representation of
MALDI PMF results for the full length ALF and ALFa proteins. ALF and ALFa MALDI spectra were analysed and using the FindMod software
(http://www.expasy.org/tools/ﬁndmod/) and tryptic peptides were predicted. Their positions on the ALF aminoacid sequence (1–486) and their
oxidation state are shown (methionine-oxidized peptides are in bold). Average mass accuracy for each analysis is also indicated. (C) Negative
MALDI spectrum of the 329-341 ALFa C-terminal peptide. Tryptic ALFa digests were analysed by MALDI MS in negative mode. The ALFa-
speciﬁc 1500.68 peak is shown. This peak was predicted to be the 329–341 C-terminal ALFa peptide by the FindPep software (http://ca.expasy.org/
tools/ﬁndpept.html). Mass accuracy was 18 ppm. (D) Positive MALDI spectrum of the 318–341 ALFa C-terminal peptide. Lys-C ALFa digests were
analysed in positive mode. The ALFa-speciﬁc 2861.28 peak is shown. This peak was predicted to be the 318–341 C-terminal ALFa peptide. Mass
accuracy was 27 ppm.
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Fig. 3. Conservation of the TFIIA/ALF cleavage site. A scheme of TFIIAa/b and ALF structure. The conserved regions of the a- and b-subunits are
shown by coloured boxes and the less conserved linker by a plain line. The locations of the A and B peptides used for antibody production are
indicated. The numbers indicate the N- and C-terminal amino acids. The region containing the cleavage site is expanded to show a sequence
alignment of ALFa from mouse, man and X. laevis with that of TFIIA from human, Drosophila rerio, rat, X. laevis, mouse, Drosophila melanogaster
and the yeasts S. pombe, and S. cerevisiae. Identical and highly conserved amino acids are shown in white on a black background. Positions with
conserved amino acids are boxed in grey. Amino acids were classiﬁed as follows: small residues, P, A, G, S, T: hydrophobic, L, I, V, A, F, M, C, Y,
W: polar/acidic, D, E, Q, N: basic, R, K, H. The C-terminal amino acid of ALFa is indicated along with the the N-terminal amino acid of
recombinant TFIIAb as deﬁned by Hoiby et al. [30].
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endogenous ALFb in the testis extracts (data not shown). Nev-
ertheless, in immunoprecipitation experiments this antibody
precipitates full length ALF and ALFa as well as TFIIAa,
but not TFIIAb (Fig. 1C, and data not shown). Together,
these results indicate that there is intermixing between the
TFIIA and ALF subunits in testis extracts (summarised in
Fig. 6).
3.4. ALF stably associates with TRF2
We next aimed to identify proteins that potentially interact
with ALF. In the ALF IP, silver staining showed a protein
of 20 kDa that copuriﬁed with ALF. MALDI PMF analysis
on tryptic digests of this 20 kDa gel slice resulted in the iden-
tiﬁcation of the TRF2 protein (number of TRF2 peptides: 10,
sequence coverage: 62%, average mass accuracy: 23 ppm). We
veriﬁed this observation, using a speciﬁc monoclonal antibody
[22]. TRF2 was present almost uniquely in the cytoplasmic ex-
tract (Fig. 1A, lane 1) and was speciﬁcally immunoprecipitated
with the ALF monoclonal antibody, whereas under the same
conditions, TBP was not precipitated (Fig. 1B, lanes 2 and
3). These results reveal the presence of a TRF2–ALF complex
in testis extracts. The reciprocal experiment could not be per-
formed as the anti-TRF2 antibody does not precipitate endog-
enous TRF2 (data not shown). Immunoprecipitation with the
TFIIAa antibody speciﬁcally coprecipitated TRF2 (Fig. 1D).
Endogenous TRF2 can hence form stable complexes with both
TFIIA and ALF subunits. In contrast, no coimmunoprecipita-
tion of TRF2 was seen with the antibodies against the ALFb-
or TFIIAb-subunits (Fig. 1C and E).3.5. Expression of ALF during mouse spermatogenesis
The above results suggest that if coexpressed at the
same developmental stages, TRF2 and ALF may form
complexes in vivo in male germ cells. While the expression
of the ALF mRNA has been described [15] the expression
proﬁle of the protein is unknown. We used the anti-ALF
monoclonal antibody to study the expression and intracel-
lular localisation of ALF during mouse spermatogenesis by
immunohistochemistry. Segments of mouse seminiferous tu-
bules corresponding to each developmental stage were iso-
lated by transillumination-assisted microdissection to make
squash preparations, where the exact stage of the cycle
was identiﬁed, and then each segment was subjected to
immunostaining.
Weak ALF expression was ﬁrst observed in the nucleus of
intermediate stage VIII pachytene (P) spermatocytes (red im-
age, Fig. 4, stage VIII), while no expression was seen in stage
VI pachytene cells, in earlier stage spermatocytes and in Sertoli
cells (see appropriate panels in Fig. 4 and data not shown).
ALF expression in pachytene cells increased through stage
XII (Fig. 4) up to meiosis, where it was excluded from the con-
densed metaphase chromatin (Fig. 4, stage XII). During sper-
miogenesis, ALF was strongly expressed in the nucleus of
haploid round spermatids (RS), but was excluded from the
heterochromatic chromocenter (Fig. 4, stages IV–VI). Expres-
sion persisted in the nucleus of early elongating spermatids
(EES) up to step 12 (Fig. 4, stages VIII–XI and data not
shown). Hence, ALF is a nuclear protein that is developmen-
tally regulated during the spermatogenic cycle (summarised
in Fig. 5A).
Fig. 4. Developmental expression proﬁle of ALF. Immunodetection of ALF in developing male germ cells. The stage of each microdissected
seminiferous tubule segment is indicated to the left of each sub-panel. The Hoechst stained DNA is shown in the center panel and the merge with the
ALF signal in the right panel. Representative examples of cell types are indicated. SP, spermatogonia; P, pachytene spermatocytes; RS, haploid
round spermatids; ES, elongating spermatids; EES, early elongating spermatids; SC, Sertoli cell; MDS, meiotic dividing spermatocytes. Stages IV,
IX, and XII: 40· magniﬁcation, stages VI and VIII: 20· magniﬁcation.
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to that of TFIIAa/b. TFIIA is upregulated in early stage
pachytene cells prior to the onset of ALF expression [16].
Both proteins are subsequently expressed in late pachytene
cells and round spermatids, but TFIIAa/b disappears in
early elongating spermatids before ALF ([16] and Fig. 5B).
Similarly, in our previous studies, we have described the
expression proﬁle of TRF2 during mouse spermatogenesis
[21,22], which is summarised in Fig. 5C. While TRF2 is
dynamically expressed during spermatogenesis it is striking
to note that it is coexpressed with ALF in the nucleus of
stages VIII–XI pachytene spermatocytes and in steps 4–8
haploid spermatids (compare Fig. 5A and C). Together with
the above in vitro studies, these results are consistent with a
developmental stage-speciﬁc association of ALF with TRF2
in vivo.4. Discussion
4.1. Proteolytic cleavage of endogenous ALF in testis
Although immunostaining showed ALF to clearly be a nu-
clear protein, the majority of ALF was found in the cytoplas-
mic fraction of the extract. ALF can therefore be readily
removed from the nucleus even under low ionic strength con-
ditions. Analogous observations were made for the TRF2 and
TFIIA factors which have been shown by immunostaining to
be predominantly nuclear [16,21], but are extracted from the
nucleus under low salt conditions. These factors are therefore
not as strongly associated with the chromatin as other proteins
like CREB which is extracted from the nucleus only at high io-
nic strength. Analogous results were obtained in HeLa cells
where although TRF2 is localised to the nucleolus, signiﬁcant
amounts can be recovered into the cytoplasmic extract [28,29].
Fig. 5. Comparison of ALF, TFIIAa/b and TRF2 expression during spermatogenesis. (A) Summary of ALF expression during spermatogenesis. The
spermatogenic diﬀerentiation programme is schematised in relation to the transillumination pattern of the seminiferous tubule at the bottom.
Representative cell types are indicated. Localised expression of ALF is indicated by red labeling. (B) TFIIAa/b expression as described [16]. (C) The
TRF2 expression proﬁle in spermatogenesis as previously described [21].
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cleaved in testis. Although ALF was shown to be cleaved in
transfected U2-OS cells ([30] and our unpublished data), our
study is the ﬁrst to describe the cleavage of the endogenous
ALF in testis. The ratio of full length ALF and the cleaved
form varies from extract to extract, but the cleaved species is
always more abundant. Incubation of testis extracts, both
cytoplasmic and total, at 37 C in vitro does not result in fur-
ther cleavage of the residual full length protein. Similarly, incu-
bation of in vitro translated ALF in testis extracts does notresult in its cleavage (our unpublished data). Thus, ALF cleav-
age is a highly regulated process in vivo. We also veriﬁed if the
cleavage was stage speciﬁc, however no signiﬁcant diﬀerences
in the ratio of the full length and processed ALF proteins were
observed in extracts from puriﬁed spermatocytes and sperma-
tids (our unpublished data). Therefore, it is probable that ALF
is proteolytically cleaved at all stages of its expression. Previ-
ously, endogenous ALF has been reported as a 52 kDa protein
in human testis extracts [18]. Although this may correspond to
the cleaved a-subunit, no details of the cleavage have been





Fig. 6. Summary of complexes detected in testis extracts. The
compositions of the homologous and heterologous ALF and TFIIA
complexes are schematised. The question mark indicates that the
existence of this complex has not been fully demonstrated.
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been observed, but the processed forms have not been analysed
[31].
We analysed the cleavage of endogenous ALF by mass spec-
trometry localising the a-subunit C-terminus to amino acid
D341 (D274 in human TFIIA). We have so far been unable to
directly identify the ALF b-subunit by mass spectrometry anal-
ysis and so we cannot conﬁrm the identity of its N-terminus.
However, the N-terminal amino acid of the b-subunit of human
TFIIA in somatic cells has been identiﬁed following transfec-
tion of recombinant TFIIA [30]. Edman degradation sequenc-
ing of the b-subunit puriﬁed from transfected cells shows the
N-terminal amino acid of the b-subunit to be D278 (D345 in
ALF) suggesting that cleavage occurs between G277 and
D278 (D345 in mALF). Hence, the C-terminus of the a-subunit
and the N-terminus of the b-subunit may be separated by three
amino acids in TFIIA and ALF (Fig. 3).
This apparent discrepancy may be explained in several ways.
Cleavage may occur between amino acids G344-D345 with
digestion of the three amino acids at the C-terminus of the
a-subunit by an exopeptidase activity. Alternatively, cleavage
may occur between amino acids D341-G342 followed by
removal of the three amino acids at the N-terminus of the
b-subunit. It is also formally possible that there may be an
inherent diﬀerence in the cleavage of TFIIA and ALF or in
the cleavage that occurs in somatic and germ cells.
Our results favour the idea that cleavage takes place at D341
and that an exopeptidase activity removes the amino acids on
the N-terminal of the b-subunit. The D341-G342 pair is highly
conserved in TFIIA and ALF from many species, better con-
served than the proposed D345 site. These amino acids are
conserved even in the yeast Saccharomyces pombe, but not in
S. cerevisiae where TOA1 is not cleaved. In contrast, G344 is
replaced by L, a radically diﬀerent amino acid, in Drosophila
where TFIIA is cleaved arguing against speciﬁc recognition
of this site. Furthermore, mutations in the TFIIA amino acids
equivalent to Q339, V340, D341, and G342 in ALF (see Fig. 3)
have a dramatic eﬀect on TFIIA cleavage, whereas mutations
of those corresponding to D341 or G342 have little eﬀect. The
QVDG peptide has been designated the cleavage recognition
sequence (CRS, see [30]) and our results suggest that this
sequence is the primary cleavage site in TFIIA and ALF.4.2. Homologous and heterologous ALF–TFIIA complexes
The X-ray crystal structure of the TFIIA complex shows
that the a-subunit interacts with the N-terminus of the c-sub-
unit through a 4 helix bundle, while the b-subunit interacts
with the C-terminal region of the c-subunit through a b-barrel
structure [14,32]. ALF has been extensively described to inter-
act with the TFIIA c-subunit [18,19]. This interaction is pre-
dominant in the formation of the heterodimeric/trimeric
ALF complex and is required for stability of the complex to
degradation by the proteasome [30]. Accordingly, both TFIIA
and ALFa- and b-subunits should be able to interact with the
c-subunit to form complexes containing TFIIA and/or ALF
subunits.
This is conﬁrmed by co-immunoprecipitation of ALFa with
TFIIAb and of ALFb with ALFa and TFIIAa. Hence, in germ
cells, there exists a series of heterologous complexes between
the ALF and the TFIIAa- and b-subunits. In addition the
small, but detectable, amount of TFIIAa that precipitates withALFa suggests that there may even be a complex comprising
unprocessed ALF associated with TFIIA (see Fig. 6).
Although it is formally possible that these complexes are
formed only in vitro in extracts, the coexpression of TFIIA
and ALF in the nucleus of late pachytene and haploid cells
strongly suggests they really exist in vivo. Similarly, it is prob-
able that the homologous and heterologous complexes exist at
all stages where TFIIA and ALF are coexpressed. However,
we cannot rule out potential developmental stage-speciﬁc
mechanisms that would control their formation.
The existence of these complexes provides increased combi-
natorial possibilities for gene speciﬁcity. Each complex may
have diﬀerent abilities to interact with other components of
the transcription apparatus allowing a combinatorial code of
speciﬁcity. For example CREM interacts with TFIIAa, but
not the ALFa-subunit [16]. CREM could therefore recruit only
the sub-population of complexes carrying this subunit to target
promoters. Further studies will be required to understand the
speciﬁcities of each complex.
The situation in mouse male germ cells where both ALF and
TFIIA are coexpressed is diﬀerent from that observed in
Xenopus where ALF is expressed in oocytes and is progres-
sively replaced by TFIIA during early embryogenesis [31]. In
this situation, there is a switch between the germ cell-speciﬁc
and somatic forms, while in testis they are coexpressed. Many
previous studies have focussed on the biochemical properties
of ALF in vitro produced as a full length recombinant protein.
While these studies are relevant for understanding situations of
mutually exclusive expression such as that found in early
Xenopus embryogenesis, our results indicate that a much more
complex situation exists in germ cells.
4.3. Developmental stage-speciﬁc formation of ALF/TFIIA–
TRF2 complexes
Endogenous ALF and TFIIA interact with TRF2 in testis
extracts. TRF2 can be coprecipitated with antibodies against
the a-subunits of both ALF and TFIIA, but not with the
TFIIA or ALF b-subunit antibodies. The b-subunit has been
R. Catena et al. / FEBS Letters 579 (2005) 3401–3410 3409shown to directly contact TBP, thus by analogy these antibod-
ies may disrupt the complex with TRF2 or their epitopes may
be masked by TRF2.
Previously, a stable complex of overexpressed TRF2 and
TFIIA was isolated from HeLa extracts [32]. In HeLa cells
however, TRF2 is localised in the nucleolus, while TFIIA is
in the nucleoplasm [28]. The TRF2–TFIIA complex therefore
likely forms in the extract, but not in the living cells. In con-
trast, in male germ cells we show that ALF and TFIIA are
coexpressed with TRF2 in the nucleus of late pachytene sper-
matocytes and round spermatids. Given the in vitro results, it
is therefore likely that the TRF2–ALF/TFIIA complexes are
formed at these developmental stages in vivo.
In conclusion, we have shown that ALF is cleaved into
a- and b-subunits in male germ cells and that these subunits
form a combinatorial series of homologous and heterologous
complexes with somatic TFIIA. ALF and TFIIA also associ-
ate with TRF2 and we propose that these complexes have spe-
ciﬁc functions in gene regulation at diﬀerent developmental
stages during spermatogenesis.
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